The outcome of high-dose chemotherapy and auto-SCT in patients with multiple myeloma: a UK/Ireland and European benchmarking comparative analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The outcome of high-dose chemotherapy and auto-SCT in patients with multiple myeloma: a UK/Ireland and European benchmarking comparative analysis

Published:2010-11-22 Issue:9 Volume:46 Page:1210-1218
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Cook G, ,Jackson G H,Morgan G J,Russell N,Kirkland K,Lee J,Pearce R,Marks D I,Pagliuca A

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2010283.pdf

Reference28 articles.

1. McElwain TJ, Powles RL . High-dose intravenous melphalan for plasma-cell leukaemia and myeloma. Lancet 1983; 2: 822–824.

2. Lazarus HM, Phillips GL, Herzig RH, Hurd DD, Wolff SN, Herzig GP . High-dose melphalan and the development of hematopoietic stem-cell transplantation: 25 years later. J Clin Oncol 2008; 26: 2240–2243.

3. Smith A, Wisloff F, Samson D . Guidelines on the diagnosis and management of multiple myeloma 2005. Br J Haematol 2006; 132: 410–451.

4. Blade J, Esteve J, Rives S, Martinez C, Rovira M, Urbano-Ispizua A et al. High-dose therapy autotransplantation/intensification vs continued standard chemotherapy in multiple myeloma in first remission. Results of a non-randomized study from a single institution. Bone Marrow Transplant 2000; 26: 845–849.

5. Attal M, Harousseau JL, Facon T, Guilhot F, Doyen C, Fuzibet JG et al. Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med 2003; 349: 2495–2502.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time to Next Treatment as a Meaningful Endpoint for Trials of Primary Cutaneous Lymphoma;Cancers;2020-08-17

2. Real-world outcomes and factors impacting treatment choice in relapsed and/or refractory multiple myeloma (RRMM): a comparison of VRd, KRd, and IRd;Expert Review of Hematology;2020-03-09

3. Productivity losses in patients with newly diagnosed multiple myeloma following stem cell transplantation and the impact of maintenance therapy;European Journal of Haematology;2019-08-12

4. The impact of age and comorbidities on practice patterns and outcomes in patients with relapsed/refractory multiple myeloma in the era of novel therapies;Journal of Geriatric Oncology;2018-03

5. Prolonged Duration of Therapy Is Associated With Improved Survival in Patients Treated for Relapsed/Refractory Multiple Myeloma in Routine Clinical Care in the United States;Clinical Lymphoma Myeloma and Leukemia;2018-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3